BIO 111
Alternative Names: BIO-111Latest Information Update: 11 Jan 2008
Price :
$50 *
At a glance
- Originator Onc Bio
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer
Most Recent Events
- 06 Oct 2005 Phase-I clinical trials in Bladder cancer in USA (unspecified route)